AIM: To assess the epistatic relationships of nitric oxide (NO) biosynthesis pathway genes in susceptibility to coronary heart disease (CHD). METHODS: A total of 2142 subjects enrolled in two case-control studies was genotyped for 7 single-nucleotide polymorphisms (SNP) within NO biosynthesis pathway genes using TaqMan assays. The association analyses were performed at both SNP and haplotype levels. Two-way SNP-SNP interactions and high-order interactions were tested using multiple unconditional logistic regression analyses and generalized multifactor dimensionality reduction (GMDR) analyses, respectively. RESULTS: Two alleles (rs1049255*C and rs841*A) were identified that were significantly associated with increased risk of CHD after adjusting for all confounders (OR=1.21, 95% CI: 1.06-1.39, combined P=0.001, P(corr)=0.007 and OR=1.30, 95% CI 1.12-1.50, combined P<0.001, P(corr)<0.001, respectively). Significant two-way SNP-SNP interactions were found between SNP rs2297518 and these two significant polymorphisms, affecting the risk of CHD (P<0.001 for both). No significant high-order interactions were identified. CONCLUSION: The results suggested that two-way SNP-SNP interactions of polymorphisms within NO biosynthesis pathway genes contribute to CHD risk.
AIM: To assess the epistatic relationships of nitric oxide (NO) biosynthesis pathway genes in susceptibility to coronary heart disease (CHD). METHODS: A total of 2142 subjects enrolled in two case-control studies was genotyped for 7 single-nucleotide polymorphisms (SNP) within NO biosynthesis pathway genes using TaqMan assays. The association analyses were performed at both SNP and haplotype levels. Two-way SNP-SNP interactions and high-order interactions were tested using multiple unconditional logistic regression analyses and generalized multifactor dimensionality reduction (GMDR) analyses, respectively. RESULTS: Two alleles (rs1049255*C and rs841*A) were identified that were significantly associated with increased risk of CHD after adjusting for all confounders (OR=1.21, 95% CI: 1.06-1.39, combined P=0.001, P(corr)=0.007 and OR=1.30, 95% CI 1.12-1.50, combined P<0.001, P(corr)<0.001, respectively). Significant two-way SNP-SNP interactions were found between SNP rs2297518 and these two significant polymorphisms, affecting the risk of CHD (P<0.001 for both). No significant high-order interactions were identified. CONCLUSION: The results suggested that two-way SNP-SNP interactions of polymorphisms within NO biosynthesis pathway genes contribute to CHD risk.
Authors: Jason H Moore; Joshua C Gilbert; Chia-Ti Tsai; Fu-Tien Chiang; Todd Holden; Nate Barney; Bill C White Journal: J Theor Biol Date: 2006-02-02 Impact factor: 2.691
Authors: M Nakayama; H Yasue; M Yoshimura; Y Shimasaki; K Kugiyama; H Ogawa; T Motoyama; Y Saito; Y Ogawa; Y Miyamoto; K Nakao Journal: Circulation Date: 1999-06-08 Impact factor: 29.690
Authors: A D Hingorani; C F Liang; J Fatibene; A Lyon; S Monteith; A Parsons; S Haydock; R V Hopper; N G Stephens; K M O'Shaughnessy; M J Brown Journal: Circulation Date: 1999-10-05 Impact factor: 29.690
Authors: Y Shimasaki; H Yasue; M Yoshimura; M Nakayama; K Kugiyama; H Ogawa; E Harada; T Masuda; W Koyama; Y Saito; Y Miyamoto; Y Ogawa; K Nakao Journal: J Am Coll Cardiol Date: 1998-06 Impact factor: 24.094
Authors: Sophia S Wang; Scott Davis; James R Cerhan; Patricia Hartge; Richard K Severson; Wendy Cozen; Qing Lan; Robert Welch; Stephen J Chanock; Nathaniel Rothman Journal: Carcinogenesis Date: 2006-03-16 Impact factor: 4.944
Authors: Pawel P Wolkow; Wladyslaw Kosiniak-Kamysz; Grzegorz Osmenda; Grzegorz Wilk; Beata Bujak-Gizycka; Adam Ignacak; Mihir Kanitkar; Malgorzata Walus-Miarka; David G Harrison; Ryszard Korbut; Maciej T Malecki; Tomasz J Guzik Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240